TEFAF SUPPORTS CANCER RESEARCH
Cancer is the most common cause of death in the world today. One out of three people is diagnosed with cancer at some point in their lives, and fifty percent of those diagnosed will die of the disease, despite such treatments as radiation therapy, chemotherapy and surgery. In the next ten years, the number of diagnoses of cancer will greatly increase, but the tide can be reversed by scientific cooperation on an international scale. Funding is crucial in ensuring that researchers can continue their work to beat cancer, and since 2005 TEFAF has supported research and international collaboration by means of a special Chair of Oncology at the research institute GROW, the School for Oncology and Developmental Biology at the Maastricht University Medical Centre.
A strong impulse to achieve international cooperations
Professor Jan Hoeijmakers
has been appointed as Visiting Professor and Chair of Oncology for 2017. He has published many important studies on the role of DNA repair in cancer and aging, and his accomplishments have been internationally recognized. A professor of molecular genetics, he is investigating the effect of DNA damage in aging and carcinogenesis as the endowed chair at Maastricht UMC + / Maastricht University, sponsored by the board of TEFAF.
The GROW research institute of Maastricht UMC + / University of Maastricht, and the Limburg Cancer Research Fund (Kankeronderzoeksfonds Limburg) annually present the TEFAF Oncology Chair award. The chair holder is a special professor in Maastricht for one year, undertaking master-classes and lectures.
The objective of attracting visiting professors is to cement Maastricht’s oncology research with highly recognized national and international research teams, raising cancer research and finally cancer treatment to a higher level. The TEFAF Oncology Chair provides a strong impulse to achieve such international cooperations.
Prof. Dr. Jan Hoeijmakers
is head of the Department of Molecular Genetics of the Erasmus Medical Center
in Rotterdam, the Netherlands. He has several awards and honors to his name, such as Spinoza
(1999), an ERC Advanced Grant
(2008) and the Mendel Medal
(2012). Additionally Hoeijmakers is a Knight in the Order of the Dutch Lion
, a member of the Royal Dutch Academy of Sciences
and has been consulted by the Nobel Committee
(2014 - 2015). Most recently he was awarded the prestigious Olav Thon international research prize of half a million euros, and awarded a second ERC Advanced Grant.
Further funding is necessary in the battle against cancer
The Cancer Research Fund Limburg collects money for cancer research at the Maastricht University Medical Centre. Research into preventing and curing cancer is much needed, but it is only through international collaboration between researchers that the battle against cancer can be won. The aim of the Cancer research fund is to decrease the incidence of cancer and increase the number of people who recover from this disease by raising funds, specifically The Cancer Research Fund
founded by Health Foundation Limburg (HFL), Maastricht University Medical Centre + (Maastricht UMC +)
and the Dutch Wilhelmina Foundation / Cancer Research Foundation (KWF)
. The foundation has a passionate ambassador in internationally renowned violinist Andre Rieu
, who was born in Maastricht.
For further information visit www.kankeronderzoekfondslimburg.nl
or you can donate directly to NL06INGB0005043912.